PolyMedix to Present Antibiotic Data at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
Five Poster Presentations with Results from Antimicrobial Studies Including PolyMedix’s Phase 1B Clinical Trial with PMX-30063
RADNOR, Pa.--(BUSINESS WIRE)-- PolyMedix, Inc. (OTC BB: PYMX), an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, will be presenting five posters at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). The Conference will take place September 12-15, 2010 at the Boston Convention and Exhibition Center in Boston, MA.
The PolyMedix presentations include the results of a Phase IB study with the company’s novel defensin mimetic antibiotic compound, PMX-30063 against MRSA in human serum. Additionally, results of a preclinical study using PMX-30063 against a panel of foodborne pathogens will also be presented.
The full schedule of Polymedix poster presentations is as follows:
“Antimicrobial Activities of Structurally Diverse Host Defense Protein Mimics”
Date/Time: Wednesday, Sept. 15, 9:00AM-11:00AM
Session: 242 – New Antimicrobial Peptides and Peptidomimetics
Abstract Number: F1-2086
Location: Exhibit Hall B1
“Antimicrobial Activities of a Novel Host Defense Protein Mimics Against Foodborne Pathogens”
Date/Time: Wednesday, Sept. 15, 9:00AM-11:00AM
Session: 242 – New Antimicrobial Peptides and Peptidomimetics
Abstract Number: F1-2085
Location: Exhibit Hall B1
“Antimicrobial Activity in Human Serum After IV Administration of PMX-30063 in a Phase I Study”
Date/Time: Wednesday, Sept. 15, 9:00AM-11:00AM
Session: 242 – New Antimicrobial Peptides and Peptidomimetics
Abstract Number: F1-2083
Location: Exhibit Hall B1
“In Vitro Antimicrobial Activities of Nonpeptidic Mimics of Host Defense Proteins Against Biowarfare Pathogens”
Date/Time: Wednesday, Sept. 15, 9:00AM-11:00AM
Session: 242 – New Antimicrobial Peptides and Peptidomimetics
Abstract Number: F1-2084
Location: Exhibit Hall B1
“Population Pharmacokinetics of PMX-30063 After Single and Repeated Intravenous Doses”
Date/Time: Sunday, Sept. 12, 11:30AM-1:30PM
Session: 002 – Pharmacology of Oxazolidinones and Miscellaneous Antibacterial Agents
Abstract Number: A1-025
Location: Exhibit Hall B1
About ICAAC
The Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) is an annual event hosted by the American Society for Microbiology and is the premier meeting on infectious diseases. For the past 50 years, the meeting has presented late-breaking scientific information featuring physicians, researchers and other healthcare professionals from around the world fostering solutions for the problem of infectious disease.
About PolyMedix, Inc.
[snip] |
